TXN and cancer: Components of the Trx system (Trx1 and thioredoxin reductase 1 (TrxR1)) are regulated by the Nrf-2 transcription factor and are highly expressed in various cancers including blood cancers, such as multiple myeloma [19] and lymphoma [22].